Skip to content
StockMarketAgent
Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

FRA/2DR stock hub

FRA/2DR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/2DRis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.1B
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/2DRFRA/2DR
Loading chart…
In the news

Latest news · FRA/2DR

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E44.1
P25 n/aP50 n/aP75 n/a
Trailing P/E9.5
P25 n/aP50 n/aP75 n/a
ROE18.4
P25 n/aP50 n/aP75 n/a
ROIC9.8
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/2DR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
190
Groups with data
11
Currency
USD
Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
1,333
Employees Change
87%
Employees Change Percent
6.98
Enterprise value
EUR 867.4M
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Electromedical and Electrotherapeutic Apparatus
Last refreshed
2026-05-10
Market cap
EUR 1.1B
Price
EUR 40
Price currency
EUR
Rev Per Employee
595,494.17x
Sic
3845
Symbol
fra/2DR
Website
https://www.inspiresleep.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
10.5%
EV Earnings
7.63x
EV/EBIT
19.89x
EV/EBITDA
13.83x
EV/FCF
10.34x
EV/Sales
1.12x
FCF yield
7.74%
Forward P/E
44.07x
P/B ratio
1.58x
P/E ratio
9.53x
P/S ratio
1.36x
PE Ratio3 Y
147.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
5.61%
EBITDA Margin
7.36%
FCF margin
10.57%
Gross margin
85.78%
Gross Profit
EUR 680.9M
Gross Profit Growth
10.39%
Gross Profit Growth Q
3.7%
Gross Profit Growth3 Y
26.22%
Gross Profit Growth5 Y
47.08%
Net Income
EUR 113.7M
Net Income Growth
97.18%
Pretax Margin
6.99%
Profit Margin
14.33%
Profit Per Employee
EUR 85,322
ROA
3.91
Roa5y
-2.57
ROCE
6.24
ROE
18.37
Roe5y
-1.28
ROIC
9.84
Roic5y
-42.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

12
MetricValue
Cagr1y
-71.24%
Cagr3y
-45.26%
Cagr5y
-24.15%
EPS Growth
106.4
FCF Growth
22.65%
FCF Growth3 Y
104.31%
OCF Growth
19.05%
OCF Growth3 Y
81.13%
Revenue Growth
8.94x
Revenue Growth Q
1.62x
Revenue Growth3 Y
25.2x
Revenue Growth5 Y
46.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 1.11
Assets
EUR 790.4M
Cash
EUR 246.2M
Current Assets
EUR 480.6M
Current Liabilities
EUR 75.8M
Debt
EUR 25.6M
Debt EBITDA
EUR 0.4
Debt Equity
EUR 0.04
Debt FCF
EUR 0.31
Equity
EUR 687.2M
Interest Coverage
374.6
Liabilities
EUR 103.2M
Long Term Assets
EUR 309.8M
Long Term Liabilities
EUR 27.4M
Net Cash
EUR 220.5M
Net Cash By Market Cap
EUR 20.35
Net Cash Growth
-24.25%
Net Debt EBITDA
EUR -3.78
Net Debt Equity
EUR -0.32
Net Debt FCF
EUR -2.63
Tangible Book Value
EUR 687.2M
Tangible Book Value Per Share
EUR 23.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.34
Inventory Turnover
0.98
Net Working Capital
EUR 167.9M
Quick ratio
4.35
Working Capital
EUR 414M
Working Capital Turnover
EUR 1.61

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
4.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
-71.21%
200-day SMA
68.94
3Y total return
-83.61%
50-day SMA
47.1
50-day SMA vs 200-day SMA
50under200
5Y total return
-74.89%
All Time High
294
All Time High Change
-86.39%
All Time High Date
2023-06-30
All Time Low
23.84
All Time Low Change
67.79%
All Time Low Date
2018-05-30
ATR
2
Ch YTD
-48.93
High
40
High52
140.8
High52 Date
2025-05-14
High52ch
-71.59%
Low
40
Low52
37.4
Low52 Date
2026-05-05
Low52ch
6.95%
Ma50ch
-15.07%
Price vs 200-day SMA
-41.98%
RSI
38.7
RSI Monthly
33.87
RSI Weekly
32.59
Sharpe ratio
-1.45x
Sortino ratio
-1.78
Total Return
4.44%
Tr YTD
-48.93
Tr1m
-11.89%
Tr1w
-15.97%
Tr3m
-27.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
EUR 44.5M
Operating Income Growth
3.02
Operating margin
5.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
26,914,591%
Shares Insiders
1.27%
Shares Institutions
116.59%
Shares Qo Q
-1.77%
Shares Yo Y
-4.44%
Short Ratio
2.35

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
EUR -28.8M
Average Volume
0.15x
Bv Per Share
23.86
CAPEX
EUR -34.5M
Ch1m
-11.89
Ch1w
-15.97
Ch1y
-71.21
Ch3m
-27.3
Ch3y
-83.61
Ch5y
-74.89
Ch6m
-42.79
Change
5.82%
Change From Open
0
Close
37.8
Days Gap
5.82
Depreciation Amortization
13,586,895.1
Dollar Volume
120
Earnings Date
2026-05-04
EBIT
EUR 44.5M
EBITDA
EUR 58.4M
EPS
EUR 3.88
F Score
5
FCF
EUR 83.9M
FCF EV Yield
9.67x
Financing CF
-89,480,208
Fiscal Year End
December
Founded
2,007
Graham Number
48.95766
Graham Upside
22.39
Income Tax
EUR -58.3M
Investing CF
10,190,775
Is Primary Listing
0
Last Earnings Date
2026-05-04
Last Report Date
2026-03-31
Ma150
65.85
Ma150ch
-39.26%
Ma20
44.87
Ma20ch
-10.85%
Net CF
39,071,865
Next Earnings Date
2026-08-03
Open
40
P FCF Ratio
12.92
P OCF Ratio
9.15
Ppne
104,943,777.1
Price Date
2026-05-08
Price EBITDA
EUR 18.55
Ptbv Ratio
1.58
Relative Volume
20x
Revenue
793,793,723x
SBC By Revenue
14.19x
Share Based Comp
112,655,332
Tax By Revenue
-7.34x
Tr6m
-42.79%
Volume
0
Z Score
16.83
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/2DR pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/2DR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-71.2%
S&P 500 1Y: n/a
3Y total return
-83.6%
S&P 500 3Y: n/a
5Y total return
-74.9%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/2DR?

Insider, institutional, and short-interest positioning.

Institutional ownership
+116.6%
Share of float held by funds and institutions
Insider ownership
+1.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
2.4 days to cover
Y/Y dilution
-4.4%
Negative means the company is buying back shares.
Technical

FRA/2DR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
38.7
Neutral momentum band
Price vs 200-day MA
-42.0%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-1.45
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/2DR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/2DR stock rating?

fra/2DR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/2DR analysis?

The full report lives at /stocks/fra/2DR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/2DR?

The latest report frames fra/2DR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/2DR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.